Europe Multimodal Image Fusion Software Market

The multimodal image fusion software market in Europe is expected to grow from US$ 80.19 million in 2021 to US$ 137.80 million by 2028; it is estimated to grow at a CAGR of 8.0% from 2021 to 2028.

Because of both technological and infrastructural changes in healthcare systems, the diagnostic industry has seen a huge increase in the number of diagnostic centers in the last few years. Further, increasing population necessitates good health, which results in surging number of hospitals and diagnostic centers. For a stronger diagnosis, these centers have all types of medical imaging equipment such as ultrasound, CT scans, and MRI scans on site. Patients go to hospitals with minor and large health issues to be diagnosed. Hospitals and diagnostics centers support doctors and physicians in providing the best care for their patients while also helping to improve their fitness. Thus, hospital and diagnostics centers form a very important part of the country’s infrastructure. Hospitals and medical centers have a greater range of diagnostic instruments on site; also, the hospitals and diagnostic centers keep upgrading themselves with the latest technologically advanced equipment and solutions. As a result of the growing number of hospitals and testing centers, there is a rise in demand for advanced solutions and equipment for patient’s services. Thus, the above-mentioned factors are fueling the growth of the multimodal image fusion software market.

In Europe, the COVID-19 pandemic has a different impact on different countries, as selective countries witnessed an increase in the number of recorded cases and subsequently attracted strict as well as longer lockdown periods or social isolation. However, Western European countries such as Germany, France, Russia, and the UK have seen a comparatively modest decrease in their growth activities because of the strong healthcare systems. To protect their citizens from the virus, the governments have made tremendous investments in backing up their healthcare systems with modern technologies, which has simplified and accelerated COVID-19 diagnosis procedures. Through such investments, European countries also focused on innovative, cost-effective solutions for care giving. According to the European Commission, the rise in the Covid-19 cases across the region has no impact on the number of patients with other diseases such as heart patients, neurological disorder patients, and Alzheimer’s across the region.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the multimodal image fusion software market. The Europe multimodal image fusion software market is expected to grow at a good CAGR during the forecast period.

 Europe Multimodal Image Fusion Software Market Revenue and Forecast to 2028 (US$ Million) 

Europe Multimodal Image Fusion Software Market Segmentation

Europe Multimodal Image Fusion Software Market – By Type

• Clinical Multimodal Imaging
• Preclinical Multimodal Imaging

Europe Multimodal Image Fusion Software Market – By Application

• Hospitals
•  Diagnostic Centers
•  Academic and Research Institutes

Europe Multimodal Image Fusion Software Market- By Country

• Germany
• France
• UK
• Italy
• Russia
• Rest of Europe

Europe Multimodal Image Fusion Software Market-Companies Mentioned

• Brainlab AG
• Bruker Corporation
• Carl Zeiss Meditec
• FUJIFILM VisualSonics, Inc.
• Intrasense SA
• Mediso Ltd
• MR Solutions Ltd.
• PerkinElmer Inc.

Europe Multimodal Image Fusion Software Market Strategic Insights

Europe Multimodal Image Fusion Software Market Segmentation Analysis

Europe Multimodal Image Fusion Software Market Report Highlights

Europe Multimodal Image Fusion Software Report Scope

Europe Multimodal Image Fusion Software Market Country and Regional Insights